Development and internal validation of a prognostic model for 15-year risk of Alzheimer dementia in primary care patients. 2022

Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.

BACKGROUND The exploitation of routinely collected clinical health information is warranted to optimize the case detection and diagnostic workout of Alzheimer's disease (AD). We aimed to derive an AD prediction score based on routinely collected primary care data. METHODS We built a cohort selecting 199,978 primary care patients 60 + part of the Health Search Database between January 2002 and 2009, followed up until 2019 to detect incident AD cases. The cohort was randomly divided into a derivation and validation sub-cohort. To identify AD and non-AD cases, we applied a clinical algorithm that involved two clinicians. According to a nested case-control design, AD cases were matched with up to 10 controls based on age, sex, calendar period, and follow-up duration. Using the derivation sub-cohort, 32 potential AD predictors (sociodemographic, clinical, drug-related, etc.) were tested in a logistic regression and selected to build a prediction model. The predictive performance of this model was tested on the validation sub-cohort by mean of explained variation, calibration, and discrimination measurements. RESULTS We identified 3223 AD cases. The presence of memory disorders, hallucinations, anxiety, and depression and the use of NSAIDs were associated with future AD. The combination of the predictors allowed the production of a predictive score that showed an explained variation (pseudo-R2) for AD occurrence of 13.4%, good calibration parameters, and an area under the curve of 0.73 (95% CI: 0.71-0.75). In accordance with this model, 7% of patients presented with a high-risk score for developing AD over 15 years. CONCLUSIONS An automated risk score for AD based on routinely collected clinical data is a promising tool for the early case detection and timely management of patients by the general practitioners.

UI MeSH Term Description Entries
D008297 Male Males
D011320 Primary Health Care Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (JAMA 1995;273(3):192) Primary Care,Primary Healthcare,Care, Primary,Care, Primary Health,Health Care, Primary,Healthcare, Primary
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
January 2021, Journal of general internal medicine,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
January 2021, Diabetes, metabolic syndrome and obesity : targets and therapy,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
January 2022, Frontiers in public health,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
July 2022, The journals of gerontology. Series A, Biological sciences and medical sciences,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
December 2021, Physiotherapy,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
January 2016, BMC medicine,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
November 2014, Alzheimer's & dementia : the journal of the Alzheimer's Association,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
May 2022, NPJ primary care respiratory medicine,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
August 2023, Zhonghua wei zhong bing ji jiu yi xue,
Giulia Grande, and Davide L Vetrano, and Ettore Marconi, and Elisa Bianchini, and Iacopo Cricelli, and Valeria Lovato, and Luisa Guglielmini, and Daiana Taddeo, and Stefano F Cappa, and Claudio Cricelli, and Francesco Lapi
July 2008, Medical care,
Copied contents to your clipboard!